Nvidia and GenScript Biotech launch AI pitch competition for life sciences
What happened
GenScript Biotech Corporation and Nvidia announced the GenScript and NVIDIA Life Sciences Startup PitchFest on October 8, 2026. The global competition is designed for startups applying artificial intelligence to therapeutic discovery and life sciences. The program combines GenScript's wet lab validation capabilities with Nvidia's accelerated computing platforms. Up to six finalists will be selected for a pitch event during JPM Week in January.
From manilatimes.net
Why it matters
The competition aims to accelerate AI drug discovery by connecting emerging companies with investors and technology leaders. The winning company will receive GenScript wet lab data credits and Brev credits from Nvidia to support its development efforts. This collaboration links Nvidia's computing platforms with GenScript's biological proof capabilities.
From manilatimes.net
Who's involved
Keep exploring
The entities involved
Related events
- Nvidia announced a new financing setup designed to support various AI companies, including Anthropic and OpenAI.
- Nvidia and Hoffmann-La Roche share interest in AI-driven therapeutics following the establishment of a new innovation center in Boston.
- Nvidia, OpenAI, and Alphabet Inc. are major players in the AI infrastructure race, with Nvidia contributing $30 billion to a funding round.
- The AI industry faces intense competitive pressures, with OpenAI relying on Nvidia for chips while balancing competition from Anthropic and managing its supply chain through partners like CoreWeave.
- SOC and Sierra AI announced a strategic partnership with Nvidia to deploy AI agents.